Total Payments
$28,794
2024 Payments
$2,362
Companies
45
Transactions
554
Medicare Patients
12,327
Medicare Billing
$1.5M
Payment Breakdown by Category
Other$14,400 (50.0%)
Food & Beverage$12,953 (45.0%)
Consulting$1,266 (4.4%)
Education$147.45 (0.5%)
Travel$28.34 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14,400 | 7 | 50.0% |
| Food and Beverage | $12,953 | 534 | 45.0% |
| Consulting Fee | $1,266 | 3 | 4.4% |
| Education | $147.45 | 9 | 0.5% |
| Travel and Lodging | $28.34 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $16,059 | 57 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,118 | 34 | $0 (2023) |
| PFIZER INC. | $1,660 | 82 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,113 | 74 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $712.77 | 27 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $684.93 | 42 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $658.62 | 44 | $0 (2024) |
| Itamar Medical Inc | $523.91 | 5 | $0 (2024) |
| HEARTFLOW, INC. | $488.09 | 5 | $0 (2024) |
| Amarin Pharma Inc. | $457.73 | 26 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,362 | 67 | Amgen Inc. ($288.59) |
| 2023 | $1,549 | 55 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($255.57) |
| 2022 | $1,734 | 67 | HeartFlow, Inc. ($273.48) |
| 2021 | $1,304 | 67 | Janssen Pharmaceuticals, Inc ($248.54) |
| 2020 | $855.78 | 41 | Amarin Pharma Inc. ($199.28) |
| 2019 | $2,483 | 88 | Boehringer Ingelheim Pharmaceuticals, Inc. ($963.50) |
| 2018 | $9,297 | 81 | Amgen Inc. ($8,118) |
| 2017 | $9,211 | 88 | Amgen Inc. ($7,020) |
All Payment Transactions
554 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $23.81 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $27.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/02/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $146.01 | General |
| Category: Coronary | ||||||
| 12/02/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/13/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: Cardiology | ||||||
| 10/29/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/28/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Cardiology | ||||||
| 10/23/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Cardiology | ||||||
| 10/22/2024 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $141.59 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/22/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $101.93 | General |
| Category: Transcatheter Valve Systems | ||||||
| 10/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Cardiology | ||||||
| 10/11/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Food and Beverage | Cash or cash equivalent | $77.14 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $23.73 | General |
| 10/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/18/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Not Applicable | ||||||
| 09/05/2024 | Itamar Medical Inc | WatchPATONE (Device) | Food and Beverage | Cash or cash equivalent | $129.38 | General |
| Category: Sleep Apnea testing | ||||||
| 09/04/2024 | ATRICURE, INC. | ATRICLIP LAA EXCLUSION SYSTEM (Device) | Food and Beverage | In-kind items and services | $81.21 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/03/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/28/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $27.33 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/27/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $2.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/13/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 3,133 | 4,566 | $1.2M | $374,547 |
| 2022 | 20 | 3,250 | 4,825 | $1.3M | $386,404 |
| 2021 | 21 | 3,066 | 4,994 | $1.2M | $370,904 |
| 2020 | 15 | 2,878 | 4,547 | $1.1M | $320,705 |
Total Patients
12,327
Total Services
18,932
Medicare Billing
$1.5M
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 779 | 1,434 | $295,404 | $129,564 | 43.9% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 172 | 174 | $200,400 | $66,678 | 33.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 200 | 201 | $286,827 | $63,091 | 22.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 165 | 646 | $101,422 | $25,577 | 25.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 141 | 141 | $45,120 | $15,741 | 34.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 257 | 260 | $53,300 | $13,742 | 25.8% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 201 | 203 | $56,231 | $10,181 | 18.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 727 | 963 | $57,780 | $9,886 | 17.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 82 | 82 | $39,396 | $8,630 | 21.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 51 | 57 | $15,846 | $7,763 | 49.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 52 | 92 | $12,972 | $5,515 | 42.5% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 23 | 23 | $17,066 | $4,032 | 23.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $6,368 | $2,621 | 41.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 35 | 35 | $8,260 | $2,099 | 25.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 20 | $5,360 | $2,059 | 38.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 21 | $4,242 | $1,975 | 46.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $4,323 | $1,507 | 34.9% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Office | 2023 | 18 | 18 | $5,355 | $1,149 | 21.4% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 34 | 34 | $4,335 | $1,037 | 23.9% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 63 | 63 | $2,394 | $553.86 | 23.1% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 37 | 37 | $3,009 | $486.02 | 16.2% |
| 93307 | Ultrasound of heart | Facility | 2023 | 12 | 12 | $1,728 | $407.04 | 23.6% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 23 | 23 | $1,081 | $254.24 | 23.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 772 | 1,357 | $279,542 | $123,975 | 44.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 194 | 195 | $278,265 | $73,296 | 26.3% |
About Dr. Han Tan, MD
Dr. Han Tan, MD is a Cardiovascular Disease healthcare provider based in Mckinney, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629011440.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Han Tan, MD has received a total of $28,794 in payments from pharmaceutical and medical device companies, with $2,362 received in 2024. These payments were reported across 554 transactions from 45 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($14,400).
As a Medicare-enrolled provider, Tan has provided services to 12,327 Medicare beneficiaries, totaling 18,932 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Mckinney, TX
- Active Since 06/13/2006
- Last Updated 01/04/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1629011440
Products in Payments
- Repatha (Biological) $15,838
- ELIQUIS (Drug) $1,939
- PRADAXA (Drug) $1,655
- ENTRESTO (Drug) $826.48
- LifeVest (Device) $712.77
- XARELTO (Drug) $684.93
- FFRct (Device) $488.09
- JARDIANCE (Drug) $463.64
- Vascepa (Drug) $457.73
- VERQUVO (Drug) $325.99
- remede System (Device) $307.11
- VYNDAQEL (Drug) $294.72
- LEQVIO (Drug) $286.38
- WatchPATONE (Device) $262.56
- WatchPAT (Device) $261.35
- Impella (Device) $226.59
- Arcalyst (Drug) $199.36
- Optimizer (Device) $175.86
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $167.64
- Azure (Device) $154.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Mckinney
Dr. Dale Yoo, M.d, M.D
Cardiovascular Disease — Payments: $814,018
Cardiovascular Disease $814,018
Dr. Muhammad Khan, Md, Facc, Fscai, MD, FACC, FSCAI
Cardiovascular Disease — Payments: $173,883
Cardiovascular Disease $173,883
Dr. Marc Krock, Md, MD
Cardiovascular Disease — Payments: $93,457
Cardiovascular Disease $93,457
Dr. Faisal Wahid, M. D, M. D
Cardiovascular Disease — Payments: $77,316
Cardiovascular Disease $77,316
Dr. Wael Abo-Auda, M.d, M.D
Cardiovascular Disease — Payments: $49,936
Cardiovascular Disease $49,936
Dr. Sunil Reddy, M.d, M.D
Cardiovascular Disease — Payments: $43,292
Cardiovascular Disease $43,292